Future planned Cephalosporins Plant
MAXHEAL acquired a pre-existing manufacturing unit at Boisar, an industrial zone in Maharashtra, situated 100 km from Mumbai. Ally Pharma Options Pvt. Ltd., a WHO-cGMP-certified unit, holds approvals from NAFDAC, FDB (Ghana), Kenya, and Uganda. Its infrastructure is par excellence and compatible with international standards.
Spread over 45,000 sq. ft. of land, the unit also features ample free space for future expansion, which is an added advantage.
| Product | Daily Production Capacity |
| Tablets | |
| Capsules | |
| Liquid Oral | |
| Ointment | |
| Dry Syrup |
| TOTAL SITE AREA | 8361 Sq Mt. |
| TOTAL CONSTRUCTED AREA | 4089 Sq Mt. |
| QC & QA AREA | 250 Sq Mt. |
| AREA FOR EXPANSION | 4022 Sq Mt. |
| FACILITIES | Tablets, Capsules, Liquid-Oral, Ointment, Dry Syrup, Pellets formation |
| EMPLOYEE STRENGTH | 125 to 150 |
| FACILITIES PLANNED | β- Lactum Unit, Sterile Ointment |
| ANNUAL MANUFACTURING CAPACITY | Tablets 60 million, Capsules 67.2 million, Bottles 19 million, Tubes 10 million |
| ACCREDITATION'S | WHO-cGMP, NAFDAC, FDB-Ghana, Food and Poison Board-Kenya, NDA-Uganda |